This is an outdated version published on 07/17/2021. Read the most recent version.

Establishment of the Brazilian Registry of Hematopoietic Stem Cell Transplantation, using the database the Center for International Blood and Marrow Transplant Research

Authors

  • Cinthya Corrêa Corrêa Hospital Israelita Albert Einstein
  • Heliz Regina Alves das Neves Hospital de Clínicas – Universidade Federal do Paraná
  • Anderson João Simione Hospital Amaral Carvalho
  • Bruna Letícia da Silva Santos Geraldo Bio Sana's
  • Marcelo Pasquini 5Clinical Trials Department of Medicine Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
  • Adriana Seber Hospital Samaritano, São Paulo
  • Carmen Silvia Vieitas Vergueiro Associação da Medula Óssea
  • Leonardo Javier Arcuri Hospital Israelita Albert Einstein
  • Carmem Maria Sales Bonfim Hospital Pequeno Príncipe
  • Fernando Barroso Duarte Hospital Universitário Walter Cantídeo
  • Mary Flowers Fred Hutchinson Cancer Research Center and the University of Washington
  • Vergílio Antonio Rensi Colturato Hospital Amaral Carvalho
  • Nelson Hamerschlak Hospital Israelita Albert Einstein

DOI:

https://doi.org/10.46765/2675-374X.2021v2n2p100

Keywords:

Hematopoietic Cell Transplant, CIBMTR, Data manager, Database, Outcomes, Information system and Brazil

Abstract

The number of hematopoietic stem cell transplantation (HSCT) in Brazil is growing rapidly. To better understand the outcomes of HSCT in Brazil, strategies have been developed with the Center for International Blood and Marrow Transplant Research (CIBMTR), using its standardized registry structure and data sharing application. The methods adopted to establish the registry were through efforts to increase the Brazilian centers that report to CIBMTR included training courses for HSCT data managers, the officialization of a multicenter HSCT study using the CIBMTR structure and the partnership between Brazilian Society of Bone Marrow Transplantation (SBTMO) and the CIBMTR. Here we describe the history for establishing the HSCT Brazilian database using the CIBMTR back to center data and present the aggregated results since 2016. We found a significant increase in the numbers of active centers reporting to CIBMTR from 11 in 2016 to 21 in 2020 corresponding to higher numbers of transplants reported to the CIBMTR from 574 to 921 in that period. The model used to generate this national database was effective as it leverages existing infrastructure to assess the activity and outcomes of HSCT in Brazil.

 

Downloads

Published

07/17/2021

Versions

How to Cite

Corrêa, C. C., das Neves, H. R. A., Simione, A. J., Geraldo, B. L. da S. S., Pasquini, M., Seber, A., Vergueiro, C. S. V., Arcuri, L. J., Bonfim, C. M. S., Duarte, F. B., Flowers, M., Colturato, V. A. R., & Hamerschlak, N. (2021). Establishment of the Brazilian Registry of Hematopoietic Stem Cell Transplantation, using the database the Center for International Blood and Marrow Transplant Research. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2(2), p100. https://doi.org/10.46765/2675-374X.2021v2n2p100

Issue

Vol. 2 No. 2 (2021): Journal of Bone Marrow Transplantation and Cellular Therapy

Section

Original article

License

License and Copyright Policy

The Journal of Bone Marrow Transplantation and Cellular Therapy (JBMTCT) adopts an open access policy, ensuring that all published articles are freely available to the public without restrictions.

  1. License

    • All articles published in JBMTCT are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
    • This license permits anyone to:
      • Share: Copy and redistribute the material in any medium or format.
      • Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
    • The only requirement is that appropriate credit is given to the original authors and source, a link to the license is provided, and any changes made are indicated.

    More information about the license can be found here: Creative Commons Attribution 4.0 International License.

  2. Authors’ Rights

    • Authors retain the copyright to their work.
    • Authors grant JBMTCT the right to publish the work and make it openly accessible online.
    • Authors are free to:
      • Distribute the published version of their article (e.g., post it on personal websites or institutional repositories).
      • Use the article in future works, presentations, or derivative publications, as long as the original publication in JBMTCT is properly acknowledged.

  3. No Embargo

    • There is no embargo period; articles are made freely available immediately upon publication.

  4. Ethical Use

    • Users of JBMTCT articles must ensure proper citation of the authors and the journal.
    • Articles must not be used in ways that violate ethical or legal standards.

  5. Disclaimer

    • While JBMTCT aims to ensure the accuracy and reliability of published content, the journal and its editors are not responsible for the consequences of its use.

For any questions regarding our licensing terms, please contact us at: journalbmtct@sbtmo.org.br 

JBMTCT is committed to the principles of open access to advance knowledge and scientific collaboration.

 

Most read articles by the same author(s)

1 2 3 4 > >>